World H, Organization WHO. WHO Global report on diabetes. 2016.

Organization WH. Obesity: preventing and managing the global epidemic: report of a WHO consultation. 2000.

Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64.

Article  CAS  PubMed  Google Scholar 

Valenzuela PL, et al. Obesity and the risk of cardiometabolic diseases. Nat Reviews Cardiol. 2023;20(7):475–94.

Article  Google Scholar 

Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184–223.

Article  PubMed  PubMed Central  Google Scholar 

Kivimäki M, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–85.

Article  PubMed  PubMed Central  Google Scholar 

Vernon G, Baranova A, Younossi Z. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Volume 34. Alimentary pharmacology & therapeutics; 2011. pp. 274–85. 3.

Estes C, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.

Article  CAS  PubMed  Google Scholar 

Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Reviews Gastroenterol Hepatol. 2013;10(6):330–44.

Article  CAS  Google Scholar 

Matteoni CA, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–9.

Article  CAS  PubMed  Google Scholar 

Kasper P, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110:921–37.

Article  PubMed  Google Scholar 

Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metabolism. 2020;42:101092.

Article  CAS  Google Scholar 

Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691–705.

Article  CAS  PubMed  Google Scholar 

Tilg H, Moschen AR, Roden M. NAFLD and Diabetes Mellitus. Nat Reviews Gastroenterol Hepatol. 2017;14(1):32–42.

Article  CAS  Google Scholar 

Targher G, et al. The complex link between NAFLD and type 2 diabetes mellitus—mechanisms and treatments. Nat Reviews Gastroenterol Hepatol. 2021;18(9):599–612.

Article  Google Scholar 

Mohamed J, et al. Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J. 2016;16(2):e132.

Article  PubMed  PubMed Central  Google Scholar 

Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiology-Gastrointestinal Liver Physiol. 2011;300(5):G697–702.

Article  CAS  Google Scholar 

Albhaisi S, Chowdhury A, Sanyal AJ. Non-alcoholic fatty liver disease in lean individuals. JHEP Rep. 2019;1(4):329–41.

Article  PubMed  PubMed Central  Google Scholar 

Musazadeh V, et al. Omega-3 polyunsaturated fatty acids in the treatment of non‐alcoholic fatty liver disease: an umbrella systematic review and meta‐analysis. Clin Exp Pharmacol Physiol. 2023;50(5):327–34.

Article  CAS  PubMed  Google Scholar 

Musazadeh V, et al. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2024;107398:p.

Google Scholar 

Farhangi MA, et al. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. J Funct Foods. 2022;92:105074.

Article  CAS  Google Scholar 

Leoni S, et al. Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol. 2018;24(30):3361.

Article  PubMed  PubMed Central  Google Scholar 

Koutoukidis DA, et al. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism. 2021;115:154455.

Article  CAS  PubMed  Google Scholar 

Hamman RF, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102–7.

Article  PubMed  Google Scholar 

Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 2014;56(4):465–72.

Article  PubMed  Google Scholar 

Bray GA, et al. Management of obesity. Lancet. 2016;387(10031):1947–56.

Article  PubMed  Google Scholar 

Varady K. Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss? Obes Rev. 2011;12(7):e593–601.

Article  CAS  PubMed  Google Scholar 

Hammer S, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol. 2008;52(12):1006–12.

Article  CAS  PubMed  Google Scholar 

Most J, et al. Calorie restriction in humans: an update. Ageing Res Rev. 2017;39:36–45.

Article  PubMed  Google Scholar 

Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines and the obesity society. Circulation. 2014;129(25suppl2):S102–38.

PubMed  Google Scholar 

Wing RR, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care. 1994;17(1):30–6.

Article  CAS  PubMed  Google Scholar 

Larson-Meyer DE, et al. Effect of 6‐month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity. 2008;16(6):1355–62.

Article  CAS  PubMed  Google Scholar 

Larson-Meyer DE, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, β-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006;29(6):1337–44.

Article  PubMed  Google Scholar 

Yoshimura E et al. Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity. Journal of obesity, 2014. 2014.

De Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381(26):2541–51.

Article  PubMed  Google Scholar 

Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing Res Rev. 2017;39:46–58.

Article  PubMed  Google Scholar 

Minciuna I, et al. Intermittent fasting—the future treatment in NASH patients? Hepatology. 2023;78(4):1290–305.

Article  PubMed  Google Scholar 

Tinsley GM, La PM, Bounty. Effects of intermittent fasting on body composition and clinical health markers in humans. Nutr Rev. 2015;73(10):661–74.

Article  PubMed  Google Scholar 

Meng H, et al. Effects of intermittent fasting and energy-restricted diets on lipid profile: a systematic review and meta-analysis. Nutrition. 2020;77:110801.

Article